- Inovio will participate in World Federation of Hemophilia World Congress in Kuala Lumpur on April 22.
- Conference presentation on DNA-encoded protein replacement therapeutics scheduled for 9:45 a.m. MYT on April 22.
- Poster session on non-viral vector FVIII expression in hemophilia A mice set for 10:45 a.m. MYT on April 22.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202604011029PR_NEWS_USPR_____PH23661) on April 01, 2026, and is solely responsible for the information contained therein.
Comments